La Jolla Pharmaceutical Company

General

Total Cases1

Active Cases1

Patents37

CourtsD. New Jersey

TypeOperating Company

Elite Ratings

--

lajollapharmaceutical.com

Ratings

Experience

Grade

Trend

DCT

--

--

--

PTAB

--

--

--

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
09/13/24	La Jolla Pharmaceutical Co v. Gland Pharma Ltd 2:22-CV-01754 ( D. NJ )	BRIEF in Support filed by LA JOLLA PHARMA, LLC, LA JOLLA PHARMACEUTICAL COMPANY, THE GEORGE WASHINGTON UNIVERSITY re [217] MOTION for Partial Summary Judgment (Attachments: # [1] Statement of Undisputed Material Facts Pursuant to Local Rule 56.1, # [2] Exhibit C, # [3] Exhibit D, # [4] Exhibit E, # [5] Exhibit F, # [6] Exhibit G, # [7] Exhibit H, # [8] Exhibit I, # [9] Exhibit J, # [10] Exhibit K, # [11] Exhibit L, # [12] Exhibit M, # [13] Exhibit N)(CHEVALIER, CHARLES)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 09/13/2024) BRIEF in Support filed by LA JOLLA PHARMA, LLC, LA JOLLA PHARMACEUTICAL COMPANY, THE GEORGE WASHINGTON UNIVERSITY re [217] MOTION for Partial Summary Judgment (Attachments: # [1] Statement of Undisputed Material Facts Pursuant to Local Rule 56.1, # [2] Exhibit C, # [3] Exhibit D, # [4] Exhibit E, # [5] Exhibit F, # [6] Exhibit G, # [7] Exhibit H, # [8] Exhibit I, # [9] Exhibit J, # [10] Exhibit K, # [11] Exhibit L, # [12] Exhibit M, # [13] Exhibit N)(CHEVALIER, CHARLES)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 09/13/2024)
09/13/24	La Jolla Pharmaceutical Co v. Gland Pharma Ltd 2:22-CV-01754 ( D. NJ )	MOTION for Partial Summary Judgment by LA JOLLA PHARMA, LLC, LA JOLLA PHARMACEUTICAL COMPANY, THE GEORGE WASHINGTON UNIVERSITY. (Attachments: # [1] Declaration of Charles H. Chevalier, # [2] Exhibit A, # [3] Exhibit B, # [4] Text of Proposed Order, # [5] Certificate of Service)(CHEVALIER, CHARLES) (Entered: 09/13/2024)
09/09/24	La Jolla Pharmaceutical Co v. Gland Pharma Ltd 2:22-CV-01754 ( D. NJ )	LETTER ORDER granting [215] Defendants request unsealing document re [211] . Signed by Magistrate Judge James B. Clark on 9/9/2024. (jd, ) Modified on 9/9/2024 (jd, ). (Entered: 09/09/2024)
09/06/24	La Jolla Pharmaceutical Co v. Gland Pharma Ltd 2:22-CV-01754 ( D. NJ )	Letter from Defendants re unsealing re [211] Letter,,. (RICHTER, JAMES) (Entered: 09/06/2024)
08/27/24	La Jolla Pharmaceutical Co v. Gland Pharma Ltd 2:22-CV-01754 ( D. NJ )	LETTER ORDER granting [213] Defendants request for an extension of time to file the motion to seal, until 9/6/2024. Signed by Magistrate Judge James B. Clark on 8/27/2024. (jd, ) (Entered: 08/27/2024)
08/27/24	La Jolla Pharmaceutical Co v. Gland Pharma Ltd 2:22-CV-01754 ( D. NJ )	LETTER ORDER granting 213 Defendants request for an extension of time to file the motion to seal, until 9/6/2024. Signed by Magistrate Judge James B. Clark on 8/27/2024. (jd, ) (Entered: 08/27/2024)
08/26/24	La Jolla Pharmaceutical Co v. Gland Pharma Ltd 2:22-CV-01754 ( D. NJ )	Letter from Defendants re extension of deadline to file motion to seal re [211] Letter,,. (RICHTER, JAMES) (Entered: 08/26/2024)
08/26/24	La Jolla Pharmaceutical Co v. Gland Pharma Ltd 2:22-CV-01754 ( D. NJ )	Letter from Defendants re extension of deadline to file motion to seal re 211 Letter,,. (RICHTER, JAMES) (Entered: 08/26/2024)
08/19/24	La Jolla Pharmaceutical Co v. Gland Pharma Ltd 2:22-CV-01754 ( D. NJ )	Minute Entry for proceedings held before Magistrate Judge James B. Clark: Telephone Conference held on 8/14/2024. (seb) (Entered: 08/19/2024)
08/14/24	La Jolla Pharmaceutical Co v. Gland Pharma Ltd 2:22-CV-01754 ( D. NJ )	LETTER ORDER: The Court will conduct a telephone status conference with the parties on October 24, 2024 at 10:00 AM. Counsel for Defendants shall initiate the call. Signed by Magistrate Judge James B. Clark on 8/14/2024. (qa, ) (Entered: 08/14/2024)